BeiGene launched the BeiGene Bioisland Innovation Center (BIC) in Guangzhou with the goal of enabling scientists and entrepreneurs to develop novel cutting-edge medical innovations. The newcos will have potential access to BeiGene support over the complete development process. The incubator will house state-of-the-art laboratory equipment and comprehensive research capabilities. The BIC center, which will have an area of 39,948 square meters in the Guangdong-Hong Kong-Macao Greater Bay Area, will eventually be home to more than 30 startup companies.
For further information, see ChinaBio Today (http://www.chinabiotoday.com/articles/beigene-guangzhou-innovation)